# Major Recall Alert: DxC 500 AU Clinical Chemistry Analyzer Recalled Due to Potential Patient Risks
On **February 13, 2025**, Beckman Coulter issued an important recall affecting their **DxC 500 AU Clinical Chemistry Analyzer**, citing a critical issue with the system's inability to recalculate results when retests are performed. This malfunction could lead to inaccurate patient data being reported, potentially resulting in unnecessary treatments, delayed interventions, or even missed diagnoses. Read on to understand the implications, actions you need to take, and how to stay informed.
---
## Why This Recall Is Important
Clinical chemistry analyzers like the **DxC 500 AU Clinical Chemistry Analyzer** play an essential role in patient diagnostics and care management. When they fail to function as intended, the consequences can directly impact patient safety. In this case, the system's inability to recalculate results when retests are conducted means operators and healthcare systems may inadvertently rely on outdated figures.
### Potential Risks Include:
- Patient treatment delays due to inaccurate results
- Unnecessary medical testing or interventions
- Misdiagnoses caused by false or outdated outcomes
Such risks emphasize the importance of immediate action from healthcare providers to ensure patient safety and proper utilization of affected devices.
---
## Details of the Recall
Beckman Coulter initiated this recall after identifying a **software issue** in their **DxC 500 AU Clinical Chemistry Analyzer**. Below are the key details:
- **Product Name**: DxC 500 AU Clinical Chemistry Analyzer
- **Brand**: Beckman Coulter
- **Recall Reason**:
- The system cannot recalculate results when performed within the calculated test.
- Results displayed to operators and LIS/middleware are based on the initial constituent tests, not updated results.
- Risks include delayed treatments or unnecessary medical interventions.
- **Recall Start Date**: February 13, 2025
- **Official Announcement Link**: [Click here for the full recall details](https://recalls-rappels.canada.ca/en/alert-recall/dxc-500-au-clinical-chemistry-analyzer)
**Image of the Affected Device:**
Healthcare professionals using this device are encouraged to review patient results critically to ensure accurate diagnoses during this recall period.
---
## What You Should Do
If you or your organization uses the **DxC 500 AU Clinical Chemistry Analyzer**, Beckman Coulter recommends taking the following steps:
- **Stop Use**: Discontinue using the affected analyzers immediately to prevent potential risks to patients.
- **Contact Beckman Coulter**: Reach out to the company for guidance on how to address this issue and request repair, replacement, or an updated system.
- **Notify Your Team**: Inform all relevant personnel about the recall to minimize the risks of inaccurate patient results being used.
- **Report Issues**: If you’ve experienced errors with this device, document the incidents and report them to Beckman Coulter or your health authority.
For further details, visit the [Beckman Coulter recall page](https://recalls-rappels.canada.ca/en/alert-recall/dxc-500-au-clinical-chemistry-analyzer).
---
## Stay Safe – Get Instant Recall Alerts
Recalls like this highlight the importance of staying informed about product safety updates that could affect your health and well-being. Protect yourself and your practice by signing up for real-time notifications with our **recall alert app**.
Stay proactive and download the app today to:
- Receive immediate alerts for recalls in your area
- Access official recall notices from trusted sources
- Ensure patient safety and effective care
**[Download the Recall App Now](#)** and never miss a critical safety alert.
---
Keeping up with recalls ensures trust in your healthcare practice and prioritizes patient safety. Share this alert with your team, patients, or anyone who may be impacted by the **DxC 500 AU Clinical Chemistry Analyzer recall**. Together, we can minimize risks and deliver accurate healthcare solutions.